Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000124477 | SCV000167910 | benign | not specified | 2014-03-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000230136 | SCV000283488 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000124477 | SCV000302202 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000124477 | SCV000336132 | benign | not specified | 2015-10-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000332566 | SCV000478504 | likely benign | Ehlers-Danlos syndrome type 7A | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312847 | SCV000738420 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2016-12-20 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000230136 | SCV002554045 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002269917 | SCV002554046 | benign | Fibromuscular dysplasia, multifocal | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002277223 | SCV002565727 | benign | Ehlers-Danlos syndrome | 2021-10-19 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002505082 | SCV002806386 | benign | Ehlers-Danlos syndrome, classic type, 1; Fibromuscular dysplasia, multifocal | 2021-11-11 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000124477 | SCV003928724 | likely benign | not specified | 2023-04-09 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003992190 | SCV004810978 | benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | COL5A1: BS1, BS2 |
Genome Diagnostics Laboratory, |
RCV000124477 | SCV002034043 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000124477 | SCV002035234 | benign | not specified | no assertion criteria provided | clinical testing |